SpeeDx, an Australian developer of molecular diagnostics solutions, has raised $15 million from US-based VC firm Northpond Ventures across two tranches.
Founded in 2009, SpeeDx focuses on in vitro diagnostic tests involving molecules that bind to certain chemicals, creating radiological markers that allow for the detection of diseases in real time. Its...
StoneWise, a Chinese biotech start-up that uses artificial intelligence (AI) technology to develop new drugs, has raised $100 million in Series B funding across two tranches.
The imminent US listing of a Middle East and North Africa (MENA) media app via a special purpose acquisition company (SPAC) is helping legitimize the region for Asian private equity.
Justin Ryan, a managing partner at Quadrant Private Equity and latterly head of the Australian firm’s growth strategy, is stepping back from day-to-day investment activity.
KKR has contributed JPY4 billion ($37 million) to a JPY6.6 billion funding round for Netstars, a Japanese QR code payment gateway operator. SIG and Lun Partners, a Hong Kong-based global financial technology investor, also took part.